English | Español

Community
+ Community
Press release submission | Nov 7, 2018

PROMIS NEUROSCIENCES, INC: Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer’s Disease
+ Regulatory
Press release submission | Nov 7, 2018

PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis
+ Technology/Innovation
Press release submission | Nov 4, 2018

ALKERMES: Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
+ Technology/Innovation
Press release submission | Nov 4, 2018

U.S. FOOD AND DRUG ADMINISTRATION: FDA permits marketing of two devices that detect parathyroid tissue in real-time during surgery
+ Technology/Innovation
Press release submission | Oct 26, 2018

ABBVIE: To Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
+ Technology/Innovation
Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
+ Community
Karen Kidd | Oct 23, 2018

Think tank founder recommends standard patents over intellectual property rights to cut drug prices
+ Community
Press release submission | Oct 18, 2018

AMERICAN BRAIN TUMOR ASSOCIATION: Launches 2018 Request for Grant Applications to Continue Driving Advances in the Brain Tumor Field

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns